DICE Therapeutics, Inc.
DICEDelisted Aug 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645569
DICE Therapeutics, Inc. was delisted on Aug 9, 2023; its insiders filed their last Form 4 on Aug 9, 2023; 160 institutions reported holding it in 13F filings for Q2 2023, worth $2.12B in total; Fairfax Financial was the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding DICE Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 115 | 160 | +45 |
| Shares | 52.1M | 45.6M | −6.49M (−12.5%) |
| Value | $1.49B | $2.12B | +$622.2M (+41.7%) |
New holders (77)
Institutions that held DICE Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (32)
Institutions that held DICE Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.